An international team of clinical collaborators, led by physician scientists from Dana-Farber Cancer Institute, performed a first-ever clinical test of the targeted therapy avapritinib in pediatric ...

A clinical trial led by researchers at the Ca' Granda Ospedale Maggiore Policlinico and the University of Milan found a probiotic mixture that significantly shortened fever duration in children with ...

An international team of clinical collaborators, led by physician scientists from Dana-Farber Cancer Institute, performed a ...

A new study shows that giving clinicians access to point-of-care testing for lipid levels increased rates of screening during ...

The Duke team performed the world’s first living mitral valve replacement, a type of partial heart transplant, which Duke ...

The FDA first approved eculizumab for use in adult patients with generalized myasthenia gravis in 2017, before expanding the ...

SAN DIEGO — Aquestive Therapeutics’ Anaphylm AQST-109 epinephrine sublingual film demonstrated durability despite testing in extreme temperatures and other environmental conditions, according ...

Dear: My local Social Security office was recently shut down because of staff layoffs and large-scale downsizing by Elon Musk ...

Vaxcyte's new pneumococcal vaccine may only have phase 1/2 results ... has started to claim market share with Vaxneuvance, which covers 15 serotypes and made sales of $665 million in 2023.

France 15 Year Government Bond 0.0100 3.7713% ...

In the early 2000s, when Dr. Alexandra Cvijanovich was completing her medical training in Utah, her team cared for a 13-year-old boy with subacute sclerosing panencephalitis, a degenerative ...

seroconversion (≥10 ELISA Ab units) Intergroup difference –5% Rubella 10–15 mIU/mL % of initially S− subjects who showed post-vac. seroconversion (≥10 IU/mL) Intergroup difference –5% ...